Your browser doesn't support javascript.
loading
Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Benson, Al B; Venook, Alan P; Adam, Mohamed; Chang, George; Chen, Yi-Jen; Ciombor, Kristen K; Cohen, Stacey A; Cooper, Harry S; Deming, Dustin; Garrido-Laguna, Ignacio; Grem, Jean L; Haste, Paul; Hecht, J Randolph; Hoffe, Sarah; Hunt, Steven; Hussan, Hisham; Johung, Kimberly L; Joseph, Nora; Kirilcuk, Natalie; Krishnamurthi, Smitha; Malla, Midhun; Maratt, Jennifer K; Messersmith, Wells A; Meyerhardt, Jeffrey; Miller, Eric D; Mulcahy, Mary F; Nurkin, Steven; Overman, Michael J; Parikh, Aparna; Patel, Hitendra; Pedersen, Katrina; Saltz, Leonard; Schneider, Charles; Shibata, David; Shogan, Benjamin; Skibber, John M; Sofocleous, Constantinos T; Tavakkoli, Anna; Willett, Christopher G; Wu, Christina; Gurski, Lisa A; Snedeker, Jenna; Jones, Frankie.
Affiliation
  • Benson AB; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Venook AP; UCSF Helen Diller Family Comprehensive Cancer Center.
  • Adam M; UCSF Helen Diller Family Comprehensive Cancer Center.
  • Chang G; The University of Texas MD Anderson Cancer Center.
  • Chen YJ; City of Hope National Medical Center.
  • Ciombor KK; Vanderbilt-Ingram Cancer Center.
  • Cohen SA; Fred Hutchinson Cancer Center.
  • Cooper HS; Fox Chase Cancer Center.
  • Deming D; University of Wisconsin Carbone Cancer Center.
  • Garrido-Laguna I; Huntsman Cancer Institute at the University of Utah.
  • Grem JL; Fred & Pamela Buffett Cancer Center.
  • Haste P; Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
  • Hecht JR; UCLA Jonsson Comprehensive Cancer Center.
  • Hoffe S; Moffitt Cancer Center.
  • Hunt S; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Hussan H; UC Davis Comprehensive Cancer Center.
  • Johung KL; Yale Cancer Center/Smilow Cancer Hospital.
  • Joseph N; University of Michigan Rogel Cancer Center.
  • Kirilcuk N; Stanford Cancer Institute.
  • Krishnamurthi S; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Malla M; O'Neal Comprehensive Cancer Center at UAB.
  • Maratt JK; Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
  • Messersmith WA; University of Colorado Cancer Center.
  • Meyerhardt J; Dana-Farber Brigham and Women's Cancer Center.
  • Miller ED; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Mulcahy MF; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Nurkin S; Roswell Park Comprehensive Cancer Center.
  • Overman MJ; The University of Texas MD Anderson Cancer Center.
  • Parikh A; Mass General Cancer Center.
  • Patel H; UC San Diego Moores Cancer Center.
  • Pedersen K; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Saltz L; Memorial Sloan Kettering Cancer Center.
  • Schneider C; Abramson Cancer Center at the University of Pennsylvania.
  • Shibata D; The University of Tennessee Health Science Center.
  • Shogan B; The UChicago Medicine Comprehensive Cancer Center.
  • Skibber JM; The University of Texas MD Anderson Cancer Center.
  • Sofocleous CT; Memorial Sloan Kettering Cancer Center.
  • Tavakkoli A; UT Southwestern Simmons Comprehensive Cancer Center.
  • Willett CG; Duke Cancer Institute.
  • Wu C; Mayo Clinic Comprehensive Cancer Center.
  • Gurski LA; National Comprehensive Cancer Network.
  • Snedeker J; National Comprehensive Cancer Network.
  • Jones F; National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 22(2 D)2024 06.
Article in En | MEDLINE | ID: mdl-38862008
ABSTRACT
Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. Management of disseminated metastatic CRC involves various active drugs, either in combination or as single agents. The choice of therapy is based on consideration of the goals of therapy, the type and timing of prior therapy, the mutational profile of the tumor, and the differing toxicity profiles of the constituent drugs. This manuscript summarizes the data supporting the systemic therapy options recommended for metastatic CRC in the NCCN Guidelines for Colon Cancer.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Natl Compr Canc Netw Journal subject: NEOPLASIAS Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Natl Compr Canc Netw Journal subject: NEOPLASIAS Year: 2024 Document type: Article